Literature DB >> 11001564

Alkaline sphingomyelinases and ceramidases of the gastrointestinal tract.

A Nilsson1, R D Duan.   

Abstract

In addition to the acid and neutral sphingomyelinases (SMase) that occur in most tissues, distinct alkaline sphingomyelinases occur in the mucosa of the gastrointestinal tract and human bile. These enzymes exhibit characteristic properties with regard to bile-salt dependence, protease resistance, and longitudinal distribution in the gut. Alkaline SMase has now been partially purified from human bile and from rat small intestine. It is thought to have a role in sphingomyelin (SM) digestion but may also be important for the generation of antiproliferative sphingolipid messengers in the gut. It occurs throughout the whole length of the intestine and also in the colon. It is decreased in colon cancer tissue compared to surrounding mucosa and is extremely low in colon mucosa from patients with familial adenomatous polyposis (FAP). This chapter reviews the properties and potential physiological and pathophysiological significance of alkaline SMase. It also briefly summarizes the knowledge about sphingolipid digestion and about the ceramidases of the gut.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11001564     DOI: 10.1016/s0009-3084(99)00078-x

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  22 in total

1.  Acid sphingomyelinase deficiency increases susceptibility to fatal alphavirus encephalomyelitis.

Authors:  Ching G Ng; Diane E Griffin
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

Review 2.  Exploring the link between ceramide and ionizing radiation.

Authors:  Massimo Aureli; Valentina Murdica; Nicoletta Loberto; Maura Samarani; Alessandro Prinetti; Rosaria Bassi; Sandro Sonnino
Journal:  Glycoconj J       Date:  2014-10       Impact factor: 2.916

Review 3.  Role of the gut in modulating lipoprotein metabolism.

Authors:  Alan A Hennessy; R Paul Ross; Gerald F Fitzgerald; Noel Caplice; Catherine Stanton
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

Review 4.  Recent advances in the immunobiology of ceramide.

Authors:  Saumya Pandey; Richard F Murphy; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2006-10-12       Impact factor: 3.362

Review 5.  Therapeutic uses of animal biles in traditional Chinese medicine: an ethnopharmacological, biophysical chemical and medicinal review.

Authors:  David Q-H Wang; Martin C Carey
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 6.  Sphingolipid metabolism and its role in the skeletal tissues.

Authors:  Zohreh Khavandgar; Monzur Murshed
Journal:  Cell Mol Life Sci       Date:  2014-11-26       Impact factor: 9.261

Review 7.  Mitochondrial ceramide and the induction of apoptosis.

Authors:  Leah J Siskind
Journal:  J Bioenerg Biomembr       Date:  2005-06       Impact factor: 2.945

Review 8.  The role of dyslipidemia in diabetic retinopathy.

Authors:  Sandra S Hammer; Julia V Busik
Journal:  Vision Res       Date:  2017-05-26       Impact factor: 1.886

9.  Distribution and properties of neutral ceramidase activity in rat intestinal tract.

Authors:  P Lundgren; A Nilsson; R D Duan
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

10.  Ezetimibe inhibits expression of acid sphingomyelinase in liver and intestine.

Authors:  Yajun Cheng; Fuli Liu; Jun Wu; Yao Zhang; Ake Nilsson; Rui-Dong Duan
Journal:  Lipids       Date:  2009-09-24       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.